EFPIA - NEWSLETTER

EFPIA Newsletter 14 December 2017

News

14 December 2017 14122017 The associations representing the European and British life science industry have...

Organisations representing the life science industry in the EU and the UK have called for medicines to be a priority...

Blogs

13 December 2017 13122017 A relentless commitment to the blame game

To really address the significant challenges faced by our healthcare systems and our society will require new levels...

12 December 2017 13122017 Drugs incentives have saved lives in Europe (Guest blog)

Without strong incentives to spur continued investment in medical innovation, we cannot hope to ensure the sustainability...

Events

26 FEB 2018

06122017 4th European Conference on Clinical Research Vienna, Austria

A EUCROF conference

Learn more →

10 MAY 2018

13122017 European Conference on Rare Diseases and Orphan Products Messe Wien Congress Center, Vienna, Austria

The largest multi-stakeholder gathering in Europe for the rare disease community

Learn more →

What we are reading

Access to clinical trials and innovative treatments at risk after Brexit 14 December 2017 (EurActiv)

Haemophilia A trial results 'mind-blowing' 14 December 2017 (BBC)

Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped 07 December 2017 (EurActiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶